Home

Biotech

Broadband

B2B Internet

Europe 2001

Internet

Internet 
Architecture

Internet 
Infrastructure

Market 2000+

Oil Services

Pharmaceutical

Regional Bank

Retail

Semiconductor

Software

Telecom

Utilities

Wireless
Fresenius Medical Care AG (NYSE:FMS)9/3/2010
most recent headlinesmore headlines:       
THURSDAY, AUGUST 26, 2010
6:27 AMFresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro - BusinessWire
TUESDAY, AUGUST 17, 2010
9:35 AMFresenius Medical Care Announces Top 10 Destinations for Dialysis Patients - BusinessWire
MONDAY, AUGUST 09, 2010
9:00 AMFresenius Medical Care Announces Winner of Ernestine M. Lowrie Award for Clinical Excellence - BusinessWire
TUESDAY, AUGUST 03, 2010
6:56 AMFresenius Medical Care Reports Strong Second Quarter and Half Year Results and Confirms Outlook for 2010 - BusinessWire
MONDAY, JULY 26, 2010
10:34 AMHospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients - PR Newswire
FRIDAY, JULY 23, 2010
7:18 AMFresenius Medical Care Enters into Long-Term Distribution Agreement in Japan and Expands Dialysis Products Business in Korea - BusinessWire
WEDNESDAY, JUNE 30, 2010
7:24 AMFresenius Medical Care Expands Dialysis Services Business in Russia - BusinessWire
THURSDAY, JUNE 10, 2010
4:31 PMFresenius Medical Care Employee Honored as Volunteer of the Year for Leadership in Haiti Relief, H1N1 Response - BusinessWire


Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

HOLDRS Defined |  HOLDRS Outstanding  |  FAQ  |  Proxies by email  |  Investment Strategies
Spin-Offs & Changes  |  Current Trading  |  Download a Prospectus  |  Site Map

Merrill Lynch, Pierce, Fenner & Smith Incorporated is a registered broker-dealer and a wholly-owned subsidiary of Bank of America Corporation.
Securities Products: Are Not FDIC Insured • Are Not Bank Guaranteed • May Lose Value.

The information in this Internet site is directed at, and is intended for distribution to, and for use by, persons in the U.S. only, and is not intended for distribution to or use by any person in any other jurisdiction. Merrill Lynch does not warrant the accuracy or completeness of any price, tax, cost basis, or other information on this site, or any investment, tax or other benefits associated with HOLDRS.

The information on HOLDRSSM contained in this Internet site is solely for informational purposes and does not constitute either an offer to sell or the solicitation of an offer to buy HOLDRS. This information on HOLDRS is not, and is not intended to be, a complete discussion of all material information you should know about HOLDRS. If you are considering whether to purchase a HOLDRS security, you should carefully read the relevant prospectus prior to making a purchase. You should not rely on the information contained in this Internet site. Please view Terms of Use and Legal Notices for additional important legal information and the terms and conditions governing your use of this site.

U.S. Patent Pending.
HOLDRS and HOLding Company Depositary ReceiptS are service marks of Merrill Lynch & Co., Inc.

© Copyright 2000, Merrill Lynch, Pierce, Fenner & Smith Incorporated. Member, Securities Investor Protection Corporation (SIPC). All rights reserved.